Table 1 Patient characteristics: overall and stratified by disease

Male (%)

50.5

39.8

60.7

<.01

Age (years) (M; SD)

56.7 (15.9)

47.7 (16.7)

65.3 (8.85)

<.01

Migrational background (%)

6.0

7.1

5.0

.36

Living alone (%)

19.3

16.3

22.3

.13

Schooling

<.01

  < 10 years (%)

57.5

40.3

74.4

  10 years (%)

26.7

33.0

20.5

  ≥ 10 years (%)

15.8

26.7

5.1

Age at diagnosis (years) (M; SD)

46.7 (17.8)

36.4 (18.3)

56.6 (10.1)

<.01

Duration of disease (years) (M; SD)

9.9 (9.1)

11.5 (9.9)

8.4 (7.9)

<.01

Inpatient treatment (%)

37.8

4.6

69.4

<.01

Time needed to visit provider of asthma/COPD treatment (min) (M; SD)

27.2 (17.6)

24.2 (16.7)

30 (18.0)

<.01

Number of visits to the provider of asthma/COPD treatment during the last year (M; SD)

4.7 (5.2)

3.0 (2.4)

6.3 (6.5)

<.01

Disease severity/control

n.a.

  CAT score

–

–

23.2 (7.2)

  ACQ score

–

1.5 (1.2)

–

Experience of severe side effects (% yes)

16.4

8.3

24.2

<.01

Number of prescribed medicines (M; SD)

4.8 (3.9)

2.7 (2.3)

6.9 (4.0)

<.01

  Number of prescribed inhalers (M; SD)

1.9 (0.9)

1.7 (0.9)

2.1 (1.0)

<.01

  Number of prescribed pills (M; SD)

2.7 (3.5)

0.8 (1.9)

4.5 (3.6)

<.01

  Number of other prescribed medicines (M; SD)

0.2 (0.6)

0.1 (0.4)

0.4 (0.7)

<.01

SF-12 PCS (M; SD)

39.0 (12.6)

46.5 (10.8)

31.8 (9.7)

<.01

SF-12 MCS (M; SD)

40.9 (13.7)

44.0 (12.4)

38.0 (14.3)

<.01

GSE (M; SD)

24.4 (6.0)

30.7 (5.0)

28.2 (6.6)

<.01

HADS-depression (M; SD)

6.7 (4.7)

5.2 (4.1)

8.3 (4.6)

<.01

HADS-anxiety(M; SD)

7.8 (4.3)

7.4 (4.2)

8.1 (4.3)

.10

BMQ- overuse (M; SD)

3.1 (0.7)

3.1 (0.7)

3.2 (0.7)

.68

BMQ- harm (M; SD)

2.4 (0.7)

2.4 (0.6)

2.5 (0.7)

.15

BMQ- utility (M; SD)

3.9 (0.7)

3.9 (0.6)

3.9 (0.7)

.61

BMQ- concerns (M; SD)

2.4 (0.8)

2.2 (0.7)

2.6 (0.8)

<.01

BMQ- necessity (M; SD)

3.8 (0.9)

3.5 (1.0)

4.1 (0.7)

<.01